13F Data
13F filer · CIK 1496201

SPHERA FUNDS MANAGEMENT LTD.

TEL AVIV, L3 · filing since Q4 2013 · last filing Aug 14, 2026
Reported value
$766.5M
+$136.9M vs prior
Positions
105
New / sold out
27 / 18
Added / reduced
33 / 30
Turnover
28.4%
buys $229.3M · sells $198.5M
Top-10 weight
34.5%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewBIOGEN INCCALL+100,000–+$21.6M
AddedCYTOKINETICS INC+180,170+452.5%+$15.3M
NewINSMED INC+118,800–+$12.7M
AddedTEVA PHARMACEUTICAL INDS LTD+363,107+31.9%+$12.3M
AddedBIOMARIN PHARMACEUTICAL INC+188,650+134.8%+$10.8M
NewRHYTHM PHARMACEUTICALS INC+80,400–+$8.9M
NewLAM RESEARCH CORP+18,470–+$8.0M
NewAPPLIED MATLS INC+11,040–+$8.0M
NewIDEAYA BIOSCIENCES INC+196,408–+$7.3M
NewNUVECTIS PHARMA INC+382,945–+$7.0M
50 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedCURIS INC-1,895,941-95.0%$-19.8M
ReducedNOVA LTD-28,197-52.8%$-15.3M
ReducedCYTOKINETICS INCCALL-159,300-61.4%$-13.6M
ReducedTOWER SEMICONDUCTOR LTD-37,470-25.7%$-9.8M
Sold outAMICUS THERAPEUTIC-603,377-100.0%$-8.7M
Sold outCELLEBRITE DI LTD-631,521-100.0%$-8.7M
Sold outAPELLIS PHARMACEUTICALS INC-214,914-100.0%$-8.6M
Sold outPALO ALTO NETWORKS INC-52,800-100.0%$-8.5M
Sold outCAMTEK LTD-53,020-100.0%$-8.0M
ReducedSPDR SERIES TRUSTPUT-50,000-25.0%$-7.9M
38 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2013: $359.0MQ1 2014: $546.6MQ2 2014: $405.8MQ3 2014: $13.4BQ4 2014: $9.5BQ1 2015: $704.5MQ2 2015: $672.9MQ3 2015: $569.1MQ4 2015: $683.0MQ1 2016: $461.4MQ2 2016: $357.4MQ3 2016: $614.2MQ4 2016: $390.8MQ1 2017: $389.2MQ2 2017: $483.3MQ3 2017: $696.8MQ4 2017: $852.2MQ1 2018: $658.6MQ2 2018: $725.4MQ3 2018: $871.1MQ4 2018: $887.2MQ1 2019: $1.1BQ2 2019: $731.0MQ3 2019: $647.3MQ4 2019: $1.2BQ1 2020: $799.5MQ2 2020: $1.1BQ3 2020: $1.0BQ4 2020: $1.1BQ1 2021: $1.3BQ2 2021: $1.5BQ3 2021: $1.2BQ4 2021: $909.6MQ1 2022: $707.6MQ2 2022: $934.9MQ3 2022: $720.5MQ4 2022: $465.9MQ1 2023: $598.4MQ2 2023: $640.4MQ3 2023: $549.0MQ4 2023: $621.3MQ1 2024: $711.7MQ2 2024: $733.2MQ3 2024: $628.4MQ4 2024: $553.1MQ1 2025: $434.3MQ2 2025: $426.1MQ3 2025: $474.1MQ4 2025: $517.3MQ1 2026: $629.7MQ2 2026: $766.5M
Q4 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1TEVA PHARMACEUTICAL INDS LTDSPONSORED ADS1,500,082$50.8M6.63%
2MINERALYS THERAPEUTICS INCCOM1,469,971$39.7M5.17%
3TOWER SEMICONDUCTOR LTDSHS NEW108,265$28.2M3.68%
4SPDR SERIES TRUSTPUTST STR SP BIOT150,000$23.7M3.10%
5SYNDAX PHARMACEUTICALS INCCOM1,014,606$22.2M2.89%
6BIOGEN INCCALLCOM100,000$21.6M2.82%
7BIOGEN INCCOM96,626$20.9M2.72%
8ULTRAGENYX PHARMACEUTICAL INCOM588,494$19.6M2.56%
9BIOMARIN PHARMACEUTICAL INCCOM328,550$18.8M2.45%
10CYTOKINETICS INCCOM NEW219,987$18.7M2.44%
95 more rows. Subscribe for $29/month to see every row, download the data and use the API.